Covered recipient · General Payments record
SURENDRA D RAO
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$3,001.37
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $815.73 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $210.06 | 2 |
| UCB, Inc. | $196.03 | 2 |
| Alexion Pharmaceuticals, Inc. | $169.97 | 2 |
| ARGENX US, INC. | $110.99 | 1 |
| Biogen, Inc. | $69.78 | 1 |
| ABBVIE INC. | $58.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $58.90 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105377664 | CMS |
| Alexion Pharmaceuticals, Inc. | $104.64 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093975044 | CMS |
| Alexion Pharmaceuticals, Inc. | $65.33 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094022872 | CMS |
| ARGENX US, INC. | $110.99 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142109125 | CMS |
| Biogen, Inc. | $69.78 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104849928 | CMS |
| Novartis Pharmaceuticals Corporation | $117.23 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087316257 | CMS |
| Novartis Pharmaceuticals Corporation | $92.83 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087316267 | CMS |
| UCB, Inc. | $113.24 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143176949 | CMS |
| UCB, Inc. | $82.79 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143176951 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.